Montana Offers $2.5 Million to Enhance Bio-Medical Research Collaborations

The Montana Department of Commerce has announced that it will provide $2.5 million in grants to support bio-medical research. Montana-based, private nonprofit research institutions are eligible to apply for the funding, which may be used to expand, renovate and purchase equipment for biomedical research. The grants also may be used to expand infrastructure that will enhance scientific collaborations within the Montana University System.

Useful Stats: R&D Performed by Industry within U.S., Per State, 2003-2007

SSTI has prepared a table displaying the amount companies spent on R&D in each state from 2003 to 2007, the state's rank in 2007, the percent change over this five-year period, and the rank of that percent change. For the U.S. as a whole, industry-funded R&D was $204 billion in 2003 and rose to $269.3 billion in 2007 - a five-year jump of 32 percent. Note, the amounts in the chart are not indexed to a single year, but reflect values from when the data was released.

Final Version of NIH Guidelines for Human Stem Cell Research Released

The National Institutes of Health (NIH) last week published the final version of its guidelines regarding human stem cell research, in part determining which human embryonic stem cells (hESCs) are eligible for research with NIH funding. The final guidelines contain adjustments from the draft version of the guidelines released on April 23 for public comment, from which the NIH received approximately 49,000 statements from advocacy groups, scientists, medical organizations, religious groups, members of Congress, and private citizens.

Useful Stats: Federal Obligations for R&D to Industry by State, 2001-2005

The NSF's Federal Funds for Research and Development series illustrates trends in the U.S. government's funding obligations for science and engineering R&D. Federal funding is distributed to government agencies, academic institutions, research centers, state and local governments, nonprofit organizations, as well as private companies.